Huons Global
휴온스글로벌 · 084110
Health Care Pharmaceuticals · KOSDAQ
Market cap US$261.5M (₩360.8B)
Overview
Huons Global is the holding company, a parent entity that controls other businesses by owning their shares, for the Huons Group, a Korean health-care conglomerate listed on KOSDAQ.
Its main subsidiaries manufacture and supply prescription medicines (including local anaesthetics and eye drops), wellness injectables, and weight-management drugs to hospitals, clinics, and pharmacies in Korea, and also produce pharmaceuticals on a contract basis for other domestic and international drug companies. As a pure holding company, Huons Global's own revenues come primarily from trademark-licensing fees, management-advisory fees, dividends from subsidiaries, and rental income.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$549.6M
- FY2024US$589.5M
- FY2025US$614.1M
Operating profit
- FY2023US$82.6M
- FY2024US$70.3M
- FY2025US$65.6M
Net income
- FY2023US$67.1M
- FY2024US$48.6M
- FY2025US$59.3M
Key ratios (FY2025)
Why it matters
Huons Global operates as a pure holding company after spinning off its bio-pharmaceutical operations into a separate subsidiary, ㈜휴온스바이오파마, leaving it with no direct manufacturing activities of its own.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?